Chen Xiang Yang
Chief Tech/Sci/R&D Officer at INNOCARE PHARMA LIMITED
Profile
Presently, Chen Xiang Yang occupies the position of Chief Technology Officer for InnoCare Pharma Ltd. He previously was Principal at Pfizer Inc. and Executive Director-Medicinal Chemistry at BioDuro (Beijing) Co., Ltd. He received an undergraduate degree from Peking University and a doctorate from Emory University.
Chen Xiang Yang active positions
| Companies | Position | Start |
|---|---|---|
| INNOCARE PHARMA LIMITED | Chief Tech/Sci/R&D Officer | 30/09/2019 |
Former positions of Chen Xiang Yang
| Companies | Position | End |
|---|---|---|
BioDuro (Beijing) Co., Ltd.
 BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 31/08/2015 |
| PFIZER, INC. | Corporate Officer/Principal | 28/02/2010 |
Training of Chen Xiang Yang
| Emory University | Doctorate Degree |
| Peking University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| INNOCARE PHARMA LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Commercial Services |
- Stock Market
- Insiders
- Chen Xiang Yang
